Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TechnipFMC plc Ordinary Share (FTI) vs Heron Therapeutics Inc (HRTX) Price & Performance

TechnipFMC plc Ordinary ShareTrade
Heron Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

TechnipFMC plc Ordinary Share vs Heron Therapeutics Inc — how do they compare? TechnipFMC plc Ordinary Share trades at $70 (market cap $27.31B), while Heron Therapeutics Inc trades at $0.4 (market cap $68.01M). The key difference: TechnipFMC plc Ordinary Share is far larger — about 401.6× Heron Therapeutics Inc's market cap, and TechnipFMC plc Ordinary Share pays a 0.29% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold TechnipFMC plc Ordinary Share for 1 Days and Heron Therapeutics Inc for 35 Days on average.

FTIHRTX
Market Cap
$27.31B$68.01M
Volume
2,496,4101,891,941
Sector
EnergyHealth
52-Week High
$80.08$1.49
52-Week Low
$35.57$0.27
Typical Hold Time
1 Days35 Days
Enterprise Value
$27.56B$174.75M
Dividend Yield
0.29%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

TechnipFMC plc Ordinary Share

No Aura AI signal available yet.

Heron Therapeutics Inc

Heron Therapeutics (HRTX) trades at $0.39, up 0.95% with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings discussions.

The outlook remains challenged by persistent losses and negative margins, though strong analyst support suggests potential upside. Key risks include execution on sales targets and achieving profitability. The stock's low price near 52-week lows presents speculative opportunity but requires careful risk management given financial performance.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FTI

No sentiment data available yet.

HRTX
8% Buy92% Sell
Avg holding period · 35 Days

About TechnipFMC plc Ordinary Share

TechnipFMC is an energy technology company providing subsea systems, surface technologies, and related services across the life of oil and gas fields. Its offerings include equipment, controls, installation support, and digital tools for offshore and onshore projects.

Read more on FTI →

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX →